Table 4.
TVM-A12 | HepG2 | A549 | |||||
---|---|---|---|---|---|---|---|
HERV-K | HERV-H | HERV-K | HERV-H | HERV-K | HERV-H | ||
HERV-K | Rho | 0.911** | 0.809** | 0.952** | |||
p | <0.001 | <0.001 | <0.001 | ||||
CD133 | Rho | 0.877** | 0.741* | 0.835** | 0.741** | 0.976** | 0.929* |
p | <0.001 | 0.001 | <0.001 | <0.001 | <0.001 | 0.001 | |
OCT4 | Rho | 0.790** | 0.729* | 0.764** | 0.475* | 0.929* | 0.881* |
p | <0.001 | 0.001 | <0.001 | 0.034 | 0.001 | 0.004 | |
NANOG | Rho | 0.784** | 0.676* | 0.856** | 0.530* | 0.930* | 0.952** |
p | <0.001 | 0.004 | <0.001 | 0.016 | 0.001 | <0.001 | |
SOX2 | Rho | 0.258 | 0.076 | 0.800** | 0.619* | 0.992** | 0.946** |
p | 0.366 | 0.778 | <0.001 | 0.004 | <0.001 | <0.001 |
Rho and p values are shown in bold when significant (p values <0.050)